Group 1 - OPKO Health reported quarterly earnings of 0.01pershare,exceedingtheZacksConsensusEstimateofalossof0.11 per share, compared to a loss of 0.09pershareayearago[1]−Theearningssurpriseforthisquarterwas109.090.03 per share against an expected loss of 0.10pershare[2]−Thecompanygeneratedrevenuesof183.6 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 18.35%, and showing a slight increase from 181.9millioninthesamequarterlastyear[3]Group2−OPKOHealthshareshaveincreasedapproximately12.90.08 on revenues of 157.35million,and−0.26 on revenues of $675.16 million for the current fiscal year [8] - The Medical - Instruments industry, to which OPKO Health belongs, is currently ranked in the top 33% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [9]